Billions of VC dollars are chasing returns in the emerging psychedelics industry. As exciting as this may seem to some, it brings a unique set of ethical challenges and questions. Who should own the future of psychedelics: corporations or communities? Can decriminalization and medicalization co-exist or are they fundamentally at odds? How will indigenous communities that stewarded plant-medicine knowledge over the millenia and victims of the Drug War that kept the psychedelic dream alive past the 1960’s be included in this new, legal psychedelic industry? What do ethical business models look like in psychedelics? Is it even possible to have an ethical, profit-seeking business in this space?

This panel will bring people from all sides of the table together to discuss and debate.